Soft tissue release therapy in abnormal menstrual cycle
Phase 1
Completed
- Conditions
- Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified
- Registration Number
- CTRI/2021/12/038511
- Lead Sponsor
- MMD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 27
Inclusion Criteria
Women in reproductive age group 18-40years.
Body Mass Index (normal18.5-24.9, over weight 25.0-29.9 kg/m2)
Chronic AUB having any of these menstrual cycle >34 days or <24 days, duration of flow >8 days <4 day, heavy bleed during cycle, primary
dysmenorrhea, oligomenorrhea
Pain as measured on VAS equal to or more than 5 at base line.
Exclusion Criteria
Pregnant females, obese females, recent incontinence surgery , neurogenic bladder, diabetic nephropathy, patient with positive urine culture, patients with painful abdominal scarsAbdominal pain due to other reasons in the last 6 months.Other pelvic disorders like PCOD/PCOS
Cardiac pacemakers, History of Tuberculosis, Thyroid disorders, Psychological distress in the last 6 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method